Abiopharma

📋 JEFFREY SHERMAN (Ex-Affliate) plans to sell 237K shares of NEOGENOMICS, INC. (at $15.64 each, total $3.7M) Filed: Jul 30, 2026 | ID: 007427

New Form SCHEDULE 13G/A - NEOGENOMICS INC <b>Filed:</b> 2026-07-30 <b>AccNo:</b> 0002012383-26-003193 <b>Size:</b> 11 KB

New Form SCHEDULE 13G - NEOGENOMICS INC <b>Filed:</b> 2026-07-30 <b>AccNo:</b> 0001445546-26-005565 <b>Size:</b> 15 KB

(30% Negative) NEOGENOMICS INC (NEO) Reports Q3 2026 Financial Results

NeoGenomics Reports Second Quarter 2026 Results

New Form 8-K/A - NEOGENOMICS INC <b>Filed:</b> 2026-07-22 <b>AccNo:</b> 0001077183-26-000049 <b>Size:</b> 153 KB <br />Item 7.01: Regulation FD Disclosure <br />Item 8.01: Other Events <br />Item 9.01: Financial Statements and Exhibits

(99% Neutral) NEOGENOMICS INC (NEO) Files Form 8-K

NeoGenomics Announces Settlement of Voluntary Disclosure to OIG-HHS

NeoGenomics Announces Settlement of Voluntary Disclosure to OIG-HHS

NeoGenomics Launches FDA-Approved PTEN IHC Companion Diagnostic for Prostate Cancer